This Article Full Text Full Text (PDF) All Versions of this Article: 90/11/6131    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Z. Articles by Jhiang, S. M. Search for Related Content PubMed PubMed Citation Articles by Zhang, Z. Articles by Jhiang, S. M. Related Collections Endocrine Oncology Thyroid

Cell Surface Targeting Accounts for the Difference in Iodide Uptake Activity between Human Na⁺/I^– Symporter and Rat Na⁺/I^– Symporter

Ohio State Biochemistry Program, Departments of Physiology and Cell Biology and Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio 43210

Address all correspondence and requests for reprints to: Dr. Sissy M. Jhiang, 304 Hamilton Hall, 1645 Neil Avenue, Ohio State University, Columbus, Ohio 43210. E-mail: jhiang.1{at}osu.edu.

Context: The Na⁺/I^– symporter (NIS) has been proposed to serve as an imaging reporter gene to optimize vector delivery, monitor therapeutic gene expression, and map the tissue/organ sites of repopulated progenitor cells in vivo. In addition, NIS can serve as a therapeutic gene to facilitate targeted radionuclide therapy for various cancers.

Objective: It was reported that rat NIS (rNIS) confers higher radioactive iodide uptake (RAIU) activity than human NIS (hNIS). We aim to investigate the mechanism underlying this difference.

Results: We showed that the open reading frames (ORF) of hNIS and rNIS, although encoding for proteins with 83% amino acid identity, exhibit a significant difference in RAIU activity in transfected cells. The ORF rNIS confers four to five times higher RAIU activity as well as cell surface NIS accumulation than ORF hNIS despite similar total NIS protein levels. Multiple regions appear to play roles in the difference in NIS cell surface levels between ORF hNIS and ORF rNIS, indicating that proper folding of NIS in tertiary structure is critical for NIS cell surface targeting. We also showed that the kinetics of Na⁺ binding are different between ORF hNIS and ORF rNIS, and that site-directed mutation changing Ser200 to other uncharged amino acid significantly increased RAIU activity in ORF hNIS.

Conclusions: NIS transgene could be optimized for cell surface trafficking and RAIU activity to improve its clinical applications.

This article has been cited by other articles:

				M. Dayem, C. Basquin, V. Navarro, P. Carrier, R. Marsault, P. Chang, S. Huc, E. Darrouzet, S. Lindenthal, and T. Pourcher Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization J. Endocrinol., April 1, 2008; 197(1): 95 - 109. [Abstract] [Full Text] [PDF]

				D. D. Vadysirisack, E. S.-W. Chen, Z. Zhang, M.-D. Tsai, G.-D. Chang, and S. M. Jhiang Identification of in Vivo Phosphorylation Sites and Their Functional Significance in the Sodium Iodide Symporter J. Biol. Chem., December 21, 2007; 282(51): 36820 - 36828. [Abstract] [Full Text] [PDF]